US 11426409
Compounds, compositions and methods for treating or preventing HER-driven drug-resistant cancers
granted A61KA61K31/519A61K45/06
Quick answer
US patent 11426409 (Compounds, compositions and methods for treating or preventing HER-driven drug-resistant cancers) held by The Regents of the University of Colorado expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/519, A61K45/06, A61P, A61P35/00